The Clinical and Molecular Characterization of Patients With Dyshormonogenic Congenital Hypothyroidism Reveals Specific Diagnostic Clues for DUOX2 Defects
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
CONTEXT: Mutations in the DUOX2 gene have been associated with transient or permanent congenital hypothyroidism due to a dyshormonogenic defect. OBJECTIVE: This study aimed to verify the prevalence of DUOX2 mutations and the associated clinical features in children selected by criteria supporting a partial iodide organification defect (PIOD). PATIENTS AND METHODS: Thirty children with PIOD-like criteria were enrolled and genotyped. A detailed clinical characterization was undertaken together with the functional analysis of the DUOX2 variations and the revision of the clinical and molecular data of the literature. RESULTS: In this large selected series, the prevalence of the DUOX2 mutations was high (37%). We identified 12 missense variants, one splice site, and three frameshift DUOX2 mutations. Functional analyses showed significant impairment of H2O2 generation with five missense variants. Stop-codon mutants were shown to totally abolish DUOX2 activity by nonsense-mediated RNA decay, exon skipping, or protein truncation. DUOX2 mutations, either mono- or biallelic, were most frequently associated with permanent congenital hypothyroidism. Moreover, the present data suggested that, together with goiter and PIOD, the most significant features to select patients for the DUOX2 analysis are the low free T4 and the high TSH concentrations at the first postnatal serum sampling, despite borderline blood spot TSH. Interestingly, the analysis of previously described DUOX2 mutated cases confirmed the validity of these findings. CONCLUSIONS: The defects in the peroxide generation system are common among congenital hypothyroidism patients with PIOD. The most robust clinical parameters for selecting patients for DUOX2 analysis have been identified, and several DUOX2 variants have been functionally characterized.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“DUOX2 mutations have also been found in patients with early-onset inflammatory bowel disease, suggesting an extrathyroidal role for DUOX2 (226,227).”
Citations
Cites
Inactivating Mutations in the Gene for Thyroid Oxidase 2 (THOX2) and Congenital Hypothyroidism
Moreno, J. C., Bikker, H., Kempers, M. J. E., van Trotsenburg, A. S. P., Baas, F., de Vijlder, J. J. M., Vulsma, T., & Ris-Stalpers, C. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012752 · Cited by 485 · cited 5×
“The frameshift p.P966Sfs*29, commonly reported as p.S965fsX994, was the most frequent DUOX2 mutations detected in our series, consistent with data in the literature.”
BackgroundMethodInfluentialPurification of a Novel Flavoprotein Involved in the Thyroid NADPH Oxidase
Dupuy, C., Ohayon, R., Valent, A., Noël-Hudson, M.-S., Dème, D., & Virion, A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.37265 · Cited by 465 · cited 5×
“org J Clin Endocrinol Metab, March 2014, 99(3):E544–E553 doi: 10.”
BackgroundInfluentialIdentification of the Maturation Factor for Dual Oxidase
Grasberger, H., & Refetoff, S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c600095200 · Cited by 332 · cited 2×
“The maturation factors DUOXA1 [DUOXA1 (MIM*612771)] and DUOXA2 [DUOXA2 (MIM *612772)] are essential components for the enzymatic activity of DUOX2 (4) because they form heterodimeric complexes with DUOX2 and allow the translocation of the dimer from endoplasmic reticulum to the membrane (5, 6).”
BackgroundCorbetta, C., Weber, G., Cortinovis, F., Calebiro, D., Passoni, A., Vigone, M. C., Beck‐Peccoz, P., Chiumello, G., & Persani, L. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03568.x · Cited by 247 · cited 2×
“Although CH can be also caused by dysgenetic defects, most CH cases have recently been found to be more frequently associated with altered function of an otherwise normally positioned thyroid gland (2).”
BackgroundSelf-citationZamproni, I., Grasberger, H., Cortinovis, F., Vigone, M. C., Chiumello, G., Mora, S., Onigata, K., Fugazzola, L., Refetoff, S., Persani, L., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2020 · Cited by 182
Self-citationMorand, S., Ueyama, T., Tsujibe, S., Saito, N., Korzeniowska, A., & Leto, T. L. (2009) · The FASEB Journal · doi:10.1096/fj.08-120006 · Cited by 172 · cited 1×
“The maturation factors DUOXA1 [DUOXA1 (MIM*612771)] and DUOXA2 [DUOXA2 (MIM *612772)] are essential components for the enzymatic activity of DUOX2 (4) because they form heterodimeric complexes with DUOX2 and allow the translocation of the dimer from endoplasmic reticulum to the membrane (5, 6).”
BackgroundMaruo, Y., Takahashi, H., Soeda, I., Nishikura, N., Matsui, K., Ota, Y., Mimura, Y., Mori, A., Sato, H., & Takeuchi, Y. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0856 · Cited by 122 · cited 1×
“S1067L) have been already reported in patients with CH, and for some of them, the definite role as pathogenic mutants or SNPs is debated (12, 14, 18, 19, 25).”
BackgroundVigone, M. C., Fugazzola, L., Zamproni, I., Passoni, A., Di Candia, S., Chiumello, G., Persani, L., & Weber, G. (2005) · Human Mutation · doi:10.1002/humu.9372 · Cited by 118
Self-citationNarumi, S., Muroya, K., Asakura, Y., Aachi, M., & Hasegawa, T. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1573 · Cited by 100 · cited 2×
“S1067L) have been already reported in patients with CH, and for some of them, the definite role as pathogenic mutants or SNPs is debated (12, 14, 18, 19, 25).”
BackgroundHeterodimerization controls localization of Duox-DuoxA NADPH oxidases in airway cells
Luxen, S., Noack, D., Frausto, M., Davanture, S., Torbett, B. E., & Knaus, U. G. (2009) · Journal of Cell Science · doi:10.1242/jcs.044123 · Cited by 91 · cited 1×
“The maturation factors DUOXA1 [DUOXA1 (MIM*612771)] and DUOXA2 [DUOXA2 (MIM *612772)] are essential components for the enzymatic activity of DUOX2 (4) because they form heterodimeric complexes with DUOX2 and allow the translocation of the dimer from endoplasmic reticulum to the membrane (5, 6).”
Background
Cited by
van Trotsenburg, P., Stoupa, A., Léger, J., Rohrer, T., Peters, C., Fugazzola, L., Cassio, A., Heinrichs, C., Beauloye, V., Pohlenz, J., et al. (2021) · Thyroid® · doi:10.1089/thy.2020.0333 · Cited by 469
“Mutations in SLC26A4/PDS (222), TPO (222a) and DUOX2 (223) have been unexpectedly found in patients with nongoitrous CH and thyroid hypoplasia, narrowing the gap between TD and dyshormonogenesis.”
BackgroundInfluentialSelf-citationHayes, P., Dhillon, S., O’Neill, K., Thoeni, C., Hui, K. Y., Elkadri, A., Guo, C. H., Kovacic, L., Aviello, G., Alvarez, L. A., et al. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.06.005 · Cited by 157
“inactivating monoallelic and biallelic DUOX2 and DUOXA2 variants have been linked to hypothyroidism.(49) In contrast to adult onset IBD, VEOIBD frequently encompasses a unique”
DIAGNOSIS OF ENDOCRINE DISEASE: Congenital hypothyroidism: update and perspectives
Peters, C., van Trotsenburg, A. S. P., & Schoenmakers, N. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0383 · Cited by 162
Self-citationA frequent oligogenic involvement in congenital hypothyroidism
de Filippis, T., Gelmini, G., Paraboschi, E., Vigone, M. C., Di Frenna, M., Marelli, F., Bonomi, M., Cassio, A., Larizza, D., Moro, M., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx145 · Cited by 145
Self-citationCongenital hypothyroidism: recent advances
Wassner, A. J., & Brown, R. S. (2015) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000181 · Cited by 120
Clinical Genetics of Congenital Hypothyroidism
Szinnai, G. (2014) · Endocrine Development · doi:10.1159/000363156 · Cited by 115
Nicholas, A. K., Serra, E. G., Cangul, H., Alyaarubi, S., Ullah, I., Schoenmakers, E., Deeb, A., Habeb, A. M., Almaghamsi, M., Peters, C., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1879 · Cited by 112
“TG mutations may result in euthyroid goiter and mild or severe hypothyroidism (18), and monoallelic and biallelic DUOX2 mutations may both cause permanent or transient CH (8, 21, 23, 25).”
BackgroundInfluentialSelf-citationCongenital hypothyroidism: insights into pathogenesis and treatment
Cherella, C. E., & Wassner, A. J. (2017) · International Journal of Pediatric Endocrinology · doi:10.1186/s13633-017-0051-0 · Cited by 106
“Similarly, the prevalence of DUOX2 variants in Italy has been reported as 15% in unselected patients with congenital hypothyroidism, 23% in those with a eutopic thyroid gland [23], and to 30–37% in those with a eutopic gland and a documented partial iodine organification disorder [24, 25].”
BackgroundH2O2 Metabolism in Normal Thyroid Cells and in Thyroid Tumorigenesis: Focus on NADPH Oxidases
Szántó, I., Pusztaszeri, M. P., & Mavromati, M. (2019) · Antioxidants · doi:10.3390/antiox8050126 · Cited by 104
Genetics and management of congenital hypothyroidism
Persani, L., Rurale, G., de Filippis, T., Galazzi, E., Muzza, M., & Fugazzola, L. (2018) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2018.05.002 · Cited by 82
Self-citationLöf, C., Patyra, K., Kuulasmaa, T., Vangipurapu, J., Undeutsch, H., Jaeschke, H., Pajunen, T., Kero, A., Krude, H., Biebermann, H., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0016 · Cited by 81
“P303R mutation has previously been shown to have a slightly lower activity compared to the wild type (30).”
BackgroundMuzza, M., & Fugazzola, L. (2017) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2017.04.006 · Cited by 76
Self-citationDigenic DUOX1 and DUOX2 Mutations in Cases With Congenital Hypothyroidism
Aycan, Z., Cangul, H., Muzza, M., Bas, V. N., Fugazzola, L., Chatterjee, V. K., Persani, L., & Schoenmakers, N. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00529 · Cited by 60
“No DUOX1-sequencing results are reported for other cases with permanent CH associated with biallelic truncating DUOX2mutations listed in Table 1, although variants in other CH-associated genes were occasionally sought (2, 6, 9, 10).”
BackgroundSelf-citationHigh frequency of mutations in 'dyshormonogenesis genes' in severe congenital hypothyroidism
Makretskaya, N., Bezlepkina, O. B., Kolodkina, A. A., Kiyaev, A. V., Vasilyev, E., Petrov, V. M., Калиненкова, С. Г., Malievskiy, O. A., Dedov, I. I., & Tiulpakov, A. N. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204323 · Cited by 60
Peters, C., Nicholas, A. K., Schoenmakers, E., Lyons, G., Langham, S., Serra, E. G., Sebire, N. J., Muzza, M., Fugazzola, L., & Schoenmakers, N. (2019) · Thyroid® · doi:10.1089/thy.2018.0587 · Cited by 57
“9 mIU/L, unlike previous studies that have studied cases recruited on the basis of higher bsTSH levels or known organification defect (10,12).”
BackgroundMethodSelf-citationMild Hypothyroidism in Childhood: Who, When, and How Should Be Treated?
Vigone, M. C., Capalbo, D., Weber, G., & Salerno, M. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2017-00471 · Cited by 51
“100mIU/ L) with low FT4, higher thyroglobulin (Tg) levels, and hyperplastic thyroid gland at birth [47].”
BackgroundSelf-citationDefects in protein folding in congenital hypothyroidism
Targovnik, H. M., Scheps, K. G., & Rivolta, C. M. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110638 · Cited by 50
Maruo, Y., Nagasaki, K., Matsui, K., Mimura, Y., Mori, A., Fukami, M., & Takeuchi, Y. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-0959 · Cited by 46
DUOX Defects and Their Roles in Congenital Hypothyroidism
Deken, X. D., & Miot, F. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9424-3_37 · Cited by 44
Structure and genetic variants of thyroglobulin: Pathophysiological implications
Citterio, C. E., Rivolta, C. M., & Targovnik, H. M. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111227 · Cited by 39
Wang, H., Kong, X., Pei, Y., Cui, X., Zhu, Y., He, Z., Wang, Y., Zhang, L., Zhuo, L., Chen, C., et al. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11078 · Cited by 36
“one is the commonly observed variable phenotype-genotype correlations in patients (5,14).”
BackgroundNeonatal Screening for Congenital Hypothyroidism: What Can We Learn From Discordant Twins?
Medda, E., Vigone, M. C., Cassio, A., Calaciura, F., Costa, P., Weber, G., de Filippis, T., Gelmini, G., Frenna, M. D., Caiulo, S., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00900 · Cited by 34
Self-citationJiang, H., Wu, J., Ke, S., Hu, Y., Fei, A., Zhen, Y., Yu, J. S., & Zhu, K. (2016) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2016.07.004 · Cited by 34
Caiulo, S., Corbetta, C., Frenna, M. D., Medda, E., Angelis, S. D., Rotondi, D., Vincenzi, G., de Filippis, T., Patricelli, M. G., Persani, L., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa789 · Cited by 33
Self-citationMatsuo, K., Tanahashi, Y., Mukai, T., Suzuki, S., Tajima, T., Azuma, H., & Fujieda, K. (2016) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2015-0400 · Cited by 33
Clinical genetics of defects in thyroid hormone synthesis
Kwak, M. J. (2018) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2018.23.4.169 · Cited by 32
Genetic analyses in a cohort of Portuguese pediatric patients with congenital hypothyroidism
Silva, R. S., Rosário, M., Grangeia, A., Costa, C., Castro-Correia, C., Alonso, I. D. C. M. P., Leão, M., & Fontoura, M. (2019) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2019-0047 · Cited by 29
Petit, I., Édouard, T., Jacques, V., Bournez, M., Cartault, A., Grunenwald, S., & Savagner, F. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.657913 · Cited by 27
“Relative to the technical limitations of direct sequencing for diagnosis, recent studies have demonstrated the efficiency of nextgeneration sequencing technology for CH screening (4, 6, 8, 19, 20).”
BackgroundJurickova, I., Bonkowski, E. L., Angerman, E. B., Novak, E. A., Huron, A., Akers, G., Iwasawa, K., Braun, T., Hadar, R., Hooker, M., et al. (2022) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izac037 · Cited by 27
NADPH Oxidases in Inflammatory Bowel Disease
Stenke, E., Bourke, B., & Knaus, U. G. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9424-3_38 · Cited by 26
Genetics of Gland-in-situ or Hypoplastic Congenital Hypothyroidism in Macedonia
Zdraveska, N., Kočova, M., Nicholas, A. K., Anastasovska, V., & Schoenmakers, N. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00413 · Cited by 24
“Monogenic DUOX2 mutations frequently cause goitrous transient CH or TSH resistance (15, 25).”
BackgroundSelf-citationClinical and genetic investigation of 136 Japanese patients with congenital hypothyroidism
Tanaka, T., Aoyama, K., Suzuki, A., Saitoh, S., & Mizuno, H. (2020) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2019-0433 · Cited by 22
“[14] clinically compared suspected partial iodine organification defects in patients with bi-allelic DUOX2 mutations and with nonDUOX2mutations.”
BackgroundMutational Spectrum Analysis of Seven Genes Associated with Thyroid Dyshormonogenesis
Chen, X., Kong, X., Zhu, J., Zhang, T., Li, Y., Ding, G., & Wang, H. (2018) · International Journal of Endocrinology · doi:10.1155/2018/8986475 · Cited by 21
“reported a high prevalence (37%) of DUOX2 mutation in a Caucasian CH cohort [27].”
BackgroundInfluentialDual Oxidase System Genes Defects in Children With Congenital Hypothyroidism
Wang, F., Li, X., Ma, R., Zhao, D., & Liu, S. (2021) · Endocrinology · doi:10.1210/endocr/bqab043 · Cited by 21
Liu, S., Zhang, W., Zhang, L., Zou, H., Lu, K., Li, Q., Xia, H., Yan, S., & Ma, X. (2016) · Oncotarget · doi:10.18632/oncotarget.10525 · Cited by 19
“S965fsX994 mutation in DUOX2 in a patient with permanent CH and PIOD [31].”
BackgroundPio, M. G., Molina, M. F., Siffo, S., Chiesa, A. E., Rivolta, C. M., & Targovnik, H. M. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.111124 · Cited by 18
Heterogeneous phenotype in children affected by non-autoimmune hypothyroidism: an update
Vigone, M. C., Frenna, M. D., & Weber, G. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0288-5 · Cited by 16
“The most significant features of patients carrying DUOX2 mutations are the presence of goitre and partial iodine organification defect, and/or the low fT4 and high TSH serum concentrations at the first postnatal serum sampling, despite borderline blood spot TSH [12].”
BackgroundSelf-citationYoshizawa-Ogasawara, A., Abe, K., Ogikubo, S., Narumi, S., Hasegawa, T., & Satoh, M. (2015) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2014-0479 · Cited by 14
Endocrine Diseases and Disorders of Thyroid Function in Newborns
Ghirri, P., Balsamo, A., Ciantelli, M., Cavarzere, P., Cicognani, A., Boldrini, A., & Cassio, A. (2018) · Springer eBooks · doi:10.1007/978-3-319-29489-6_259 · Cited by 13
Baz-Redón, N., Antolín, M., Clemente, M., Campos-Martorell, A., Mogas, E., Fernández‐Cancio, M., Zafon, E., García‐Arumí, E., Soler, L., González-Llorens, N., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158473 · Cited by 13
“Highlighted variants with pathogenic functional studies described.”
Sun, F., Zhang, R., Cheng, F., Fang, Y., Yang, R., Ye, X., Han, B., Zhao, S., Dong, M., & Song, H. (2021) · Clinical Genetics · doi:10.1111/cge.14065 · Cited by 13
“found in CH patients, their correlation with patient phenotypes has not been clearly defined.(9) It has been speculated that biallelic and monoallelic mutations in DUOX2 may be associated with permanent and transient CH, respectively.”
BackgroundCirello, V., Colombo, C., Karapanou, O., Pogliaghi, G., Persani, L., & Fugazzola, L. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.589340 · Cited by 11
Self-citationSun, F., Fang, Y., Zhang, M., Zhang, R., Wu, F., Yang, R., Tu, P.-H., Dong, M., Zhao, S., & Song, H. (2021) · Endocrinology · doi:10.1210/endocr/bqab101 · Cited by 11
Molina, M. F., Papendieck, P., Sobrero, G. M., Balbi, V. A., Belforte, F. S., Bueno‐Martínez, E., Adrover, E., Olcese, M. C., Chiesa, A. E., Miras, M. B., et al. (2022) · Endocrine · doi:10.1007/s12020-022-03054-3 · Cited by 10
Fan, X., Chen, S., Qian, J., Sooranna, S. R., Luo, J., Li, C., Tang, Q., & Caijuan, L. (2015) · Global Pediatric Health · doi:10.1177/2333794x14567193 · Cited by 10
“The etiology of TCH is complex, with several factors correlating to the disease including prematurity, low birth weight, intake of iodine, as well as genetic factors.(18,19) Based on the available data of gender, gestational age, birth weight, and TSH and FT4 values, the cause of the high incidence of CH was investiga…”
van Trotsenburg, A. S. P., Stoupa, A., Léger, J., Rohrer, T. R., Peters, C. J., Fugazzola, L., Cassio, A., Heinrichs, C., Beauloye, V., Pohlenz, J., et al. (2021) · Yearbook of pediatric endocrinology · doi:10.1530/ey.18.3.8 · Cited by 9
Self-citationGENETIC DEFECTS IN THYROID HORMONE SUPPLY
Nettore, I. C., Fenzi, G., & Macchia, P. E. (2014) · Cited by 9
Fernández‐Cancio, M., Antolín, M., Clemente, M., Campos-Martorell, A., Mogas, E., Baz-Redón, N., Leno-Colorado, J., Comas-Armangué, G., García‐Arumí, E., Soler, L., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1367808 · Cited by 8
DUOX1 and DUOX2, DUOXA1 and DUOXA2
Miot, F., & Deken, X. D. (2023) · Springer eBooks · doi:10.1007/978-3-031-23752-2_14 · Cited by 8
Gavryutina, I., Fordjour, L., & Chin, V. L. (2022) · Endocrines · doi:10.3390/endocrines3020018 · Cited by 8
Levaillant, L., Bouhours‐Nouet, N., Illouz, F., Jager, J. A., Bachelot, A., Barat, P., Baron, S., Bensignor, C., de la Perrière, A. B., Djellas, Y. B., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad119 · Cited by 7
Molecular and Clinical Features of Congenital Hypothyroidism Due to Multiple DUOX2 Variants
Uehara, E., Abe, K., Tanase‐Nakao, K., Muroya, K., Hattori, A., Matsubara, K., Fukami, M., & Narumi, S. (2024) · Thyroid · doi:10.1089/thy.2024.0046 · Cited by 7
Belforte, F. S., Citterio, C. E., Testa, G., Olcese, M. C., Sobrero, G. M., Miras, M. B., Targovnik, H. M., & Rivolta, C. M. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.10.014 · Cited by 7
“19 Direct sequencing of DUOX2 exon 24 revealed the presence of the p.1067S>L polymorphism 20 [Maruo et al., 2008; Muzza et al., 2014] in all members of the family, in homozygous state.”
BackgroundInfluentialYuan, H., Meng, Z., Zhang, L., Luo, X., Liu, L., Chen, M., Li, X., Zhao, W., & Liang, L. (2016) · Molecular Cytogenetics · doi:10.1186/s13039-016-0214-3 · Cited by 7
“The loss of function mutations in these genes could cause permanent congenital hypothyroidism [17–20].”
BackgroundTrivedi, V., Kore, H., Poojary, D., Noronha, V., Bal, M. M., Chandrani, P., Choughule, A. B., Pange, P., Gupta, V., Menon, N. S., et al. (2025) · JCO Global Oncology · doi:10.1200/go-25-00043 · Cited by 6
“19 This suggests that the observed mutation could have cancer-related characteristics.”
Knowns and unknowns about congenital hypothyroidism: 2022 update
Itonaga, T., Hasegawa, Y., Higuchi, S., Satoh, M., Sawada, H., Shimura, K., Takahashi, I., Takubo, N., & Nagasaki, K. (2022) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.2022-0016 · Cited by 7
“Maruo patients with a DUOX2 variant overlapped with that in patients without the variant, the former had more severe symptoms along with a higher serum Tg level at diagnosis (median: 655 vs 426 ng/mL; range: 403–1,991 vs 54.4–3,000) (57).”
InfluentialThyroid Hormones and Brain Development
Bernal, J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803592-4.00100-0 · Cited by 6
Expanding the phenotype of thrombocytopenia absent radius syndrome with hypospadias
Miertuš, J., Maltese, P. E., Hýblová, M., Tomková, E., Ďurovčíková, D., Rísová, V., & Bertelli, M. (2020) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2020.02.011 · Cited by 5
Identification and analyzes of DUOX2 mutations in two familial congenital hypothyroidism cases
Li, L., Liu, W., Zhang, L., Wang, F., Wang, F., Gu, M., Wang, X., & Liu, S. (2020) · Endocrine · doi:10.1007/s12020-020-02437-8 · Cited by 5
Clinical Relevance of Molecular Diagnosis in Patients with Congenital Hypothyroidism
Nicola, J. P. (2017) · Journal of Molecular and Genetic Medicine · doi:10.4172/1747-0862.1000240 · Cited by 5
“[18] showed that congenital hypothyroidism due to DUOX2 mutations is permanent in 65% of cases but transient in 35%; consistent with this observation DUOX2 mutations may result in a clinical spectrum of disease ranging from congenital hypothyroidism to euthyroid goiter in adulthood.”
BackgroundDouble variants in TSHR and DUOX2 in a patient with hypothyroidism: case report
Sasivari, Z., Szinnai, G., Seebauer, B., Konrad, D., & Lang‐Muritano, M. (2019) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2019-0051 · Cited by 4
Subclinical Hypothyroidism in Infancy: To Treat or Not to Treat, That Is the Question
Wassner, A. J., & Brown, R. S. (2015) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.12.001 · Cited by 4
Cosmo, C. D., & Tonacchera, M. (2018) · Endocrinology · doi:10.1007/978-3-319-45013-1_11 · Cited by 4
Genetic Causes of Congenital Hypothyroidism
Schoenmakers, N. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65336-9 · Cited by 4
Self-citationEndocrine Diseases and Disorders of Thyroid Function in Newborns
Ghirri, P., Balsamo, A., Ciantelli, M., Cavarzere, P., Cassio, A., Cicognani, A., & Boldrini, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-18159-2_259-1 · Cited by 3
Peters, C. J., & Schoenmakers, N. A. (2019) · Wiley eBooks · doi:10.1002/9781119152712.ch8 · Cited by 3
Self-citationCongenital hepatic fibrosis in a young boy with congenital hypothyroidism: A case report
Xiao, F., Wang, Y., Dong, F., Li, X., & Zhang, T. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i6.1475 · Cited by 3
Su, Y., Lei, X., Muhetaer, A., He, J., & Li, L. (2025) · International Journal of Neonatal Screening · doi:10.3390/ijns11040098 · Cited by 2
Tan, M., Jiang, X., Mei, H.-F., Feng, Y., Xie, T., Tang, C., Chen, Q.-Y., Zeng, C., & Huang, Y. (2022) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2022-0107 · Cited by 2
Approach to the patient: genetics and management of congenital hypothyroidism
Quoc, A. N., Kariyawasam, D., Polak, M., Carré, A., & Stoupa, A. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag215 · Cited by 1
[Advances in genetic research of congenital hypothyroidism in China].
Chen, X.-Y., & Qin, X. (2018) · PubMed · doi:10.7499/j.issn.1008-8830.2018.03.015 · Cited by 1
Transient congenital hypothyroidism – too short to be transient
Subramaniam, K. (2021) · Journal of Postgraduate Medicine · doi:10.4103/jpgm.jpgm_1308_20 · Cited by 1
“[8,9] In a study from the UK, this particular mutation occurred frequently in South Asians.”
Stoupa, A., Carré, A., Polak, M., & Szinnai, G. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-812531-1.00013-0 · Cited by 1
Análise molecular de pacientes com hipotireoidismo congênito por defeito na organificação do iodeto
Brust, E. S. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2014.tde-26012015-093724
Transient Neonatal Hypothyroidism
Caiulo, S., Vigone, M. C., & Weber, G. (2015) · Springer eBooks · doi:10.1007/978-3-319-19213-0_8
Self-citationFugazzola, L. (2019) · L Endocrinologo · doi:10.1007/s40619-019-00626-w
Self-citationColomer, L. S. (2020) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Cosmo, C. D., & Tonacchera, M. (2018) · Endocrinology · doi:10.1007/978-3-319-29195-6_11-1
Endocrine Diseases and Disorders of Thyroid Function in Newborns
Ghirri, P., Balsamo, A., Ciantelli, M., Cavarzere, P., Cassio, A., Cicognani, A., & Boldrini, A. (2018) · Springer eBooks · doi:10.1007/978-3-319-18159-2_259-2
de Barcelos, I. P., Li, D., Watson, D. J., McCormick, E. M., Elden, L. M., Aleman, T. S., O'Neil, E. C., Falk, M. J., & Hakonarson, H. H. (2023) · Brain Sciences · doi:10.3390/brainsci13081210
“G250R), which was previously described in the homozygous state in two apparently unrelated Indian girls affected by retinitis pigmentosa, polydactyly, obesity, and developmental delay [4,5].”
BackgroundEstoppey-Fehlmann, J., Szinnai, G., Heinimann, K., Seebauer, B., Flück, C. E., & Janner, M. (2023) · Archives of Pediatrics · doi:10.29011/2575-825x.100279
“Alternatively, oligogenic involvement has been discussed as an explanation for intrafamilial variability in COH [30].”
BackgroundHuang, X., Shao, Q., Weng, S., Chen, W., Yuan, W., Tan, J., Yang, X., & Su, X. (2024) · Biomedical Reports · doi:10.3892/br.2024.1908
Genetic causes of congenital hypothyroidism
Schoenmakers, N. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00172-2
Self-citationIngelfinger, E. C. (2022) · Gutenberg Open Science · doi:10.25358/openscience-8171
Liang, S.-B., Cheng, C.-Y., Chen, Y.-R., Chen, Y. J., Yang, C., Lu, Y.-H., & Niu, D.-M. (2026) · Journal of the Endocrine Society · doi:10.1210/jendso/bvag081
“Patients may exhibit transient or persistent CH with wide variation in LT4 dose requirements and treatment duration [13, 16, 24-27].”
Brust, E. S., Caso, G. F., Suetsugu, R. C. D. S., de Oliveira, P. R., Lambiasi, G. T. D. M., Cerqueira, T. L. D. O., Amorim, T., Medeiros-Neto, G., Friguglietti, C. U. M., Deprá, I. C., et al. (2026) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2026.112923
Fernández-Cancio, M., Antolín, M., Clemente, M., Campos-Martorell, A., Mogas, E., Baz-Redón, N., Leno-Colorado, J., Comas-Armangué, G., García-Arumí, E., Soler-Colomer, L., et al. (2024) · doi:10.3389/fendo.2024.1367808.s001
Metadata
- Authors
- Muzza, M., Rabbiosi, S., Vigone, M. C., Zamproni, I., Cirello, V., Maffini, M. A., Maruca, K., Schoenmakers, N., Beccaria, L., Gallo, F., Park, S.-M., Beck-Peccoz, P., Persani, L., Weber, G., & Fugazzola, L.
- Affiliations
- University of Milan (IT)
- Vita-Salute San Raffaele University (IT)
- University of Cambridge (GB)
- Alessandro Manzoni Hospital (IT)
- Ospedale A. Perrino (IT)
- Addenbrooke's Hospital (GB)
- Department of Clinical Sciences and Community Health (M.M., V.C., M.A.M., P.B.-P., L.F.), University of Milan, and Endocrine Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Ca' Granda, 20122 Milan, Italy
- Corresponding author
- Fugazzola, L.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2014-03-01
- Volume
- 99
- Issue
- 3
- Pages
- E544-E553
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2040901066
- Cited by
- 83
- References
- 27
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 5 · 2023: 5 · 2022: 5 · 2021: 9 · 2020: 8 · 2019: 10 · 2018: 12 · 2017: 5 · 2016: 9 · 2015: 7 · 2014: 3
- FWCI
- 6.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust (100574)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- iodide organification defect, hydrogen peroxide production, nonsense-mediated mRNA decay, exon skipping, missense mutations, frameshift mutation, thyroid-stimulating hormone, free thyroxine, goiter, children
- MeSH terms
- Dual Oxidases, Child, Child, Preschool, Congenital Hypothyroidism, DNA Mutational Analysis, Gene Frequency, HeLa Cells, Humans, Infant, NADPH Oxidases, Mutation, Missense, Polymorphism, Single Nucleotide, Genetic Association Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.